Published in Clin Gastroenterol Hepatol on August 01, 2006
Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol (2006) 1.50
Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach. World J Gastroenterol (2008) 0.80
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med (2011) 3.52
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol (2008) 2.39
Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol (2006) 2.38
Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol (2010) 2.37
AGA Institute review of endoscopic sedation. Gastroenterology (2007) 2.35
Prediction of Barrett's esophagus among men. Am J Gastroenterol (2013) 2.22
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med (2009) 2.19
Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09
Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc (2008) 1.96
Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. Am J Gastroenterol (2009) 1.74
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl (2011) 1.67
The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65
A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol (2004) 1.51
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol (2005) 1.50
National Institutes of Health consensus development conference statement: management of hepatitis B. Hepatology (2009) 1.48
Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol (2008) 1.38
Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care (2010) 1.35
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology (2013) 1.32
Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. Clin Gastroenterol Hepatol (2007) 1.25
Women patients' preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc (2005) 1.20
Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol (2008) 1.20
Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc (2011) 1.18
Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus. Gastroenterology (2013) 1.09
Cost-effective treatment of patients with symptomatic cholelithiasis and possible common bile duct stones. J Am Coll Surg (2011) 1.07
The impact of the quality of colon preparation on follow-up colonoscopy recommendations. Am J Gastroenterol (2011) 1.04
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol (2010) 1.03
Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc (2009) 1.02
Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol (2005) 1.01
Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS (2015) 0.99
Why you should care about screening flexible sigmoidoscopy. N Engl J Med (2012) 0.99
Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus. Gut (2013) 0.98
Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2010) 0.96
Management of obscure occult gastrointestinal bleeding: a cost-minimization analysis. Clin Gastroenterol Hepatol (2008) 0.95
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol (2012) 0.94
On-demand therapy for gastroesophageal reflux disease. Am J Gastroenterol (2007) 0.94
Quality indicators for EGD. Gastrointest Endosc (2014) 0.92
Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci (2010) 0.90
In search of quality colonoscopy. Gastroenterology (2008) 0.89
Quality indicators for EGD. Am J Gastroenterol (2014) 0.87
Performance of Lynch syndrome predictive models in a multi-center US referral population. Am J Gastroenterol (2011) 0.86
Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome. Cancer (2012) 0.86
Anesthesia for colonoscopy: too much of a good thing? JAMA Intern Med (2013) 0.83
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt. Clin Gastroenterol Hepatol (2009) 0.83
Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med (2002) 0.83
Non-English speakers attend gastroenterology clinic appointments at higher rates than English speakers in a vulnerable patient population. J Clin Gastroenterol (2009) 0.83
Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families. Fam Cancer (2006) 0.82
Risk stratification in upper gastrointestinal bleeding. J Clin Gastroenterol (2007) 0.82
Time to burn? Endoscopic ablation for Barrett's esophagus. Gastroenterology (2011) 0.79
Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation. Am J Gastroenterol (2010) 0.79
A glossary of economic terms. Eur J Gastroenterol Hepatol (2004) 0.78
Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable? Hepatology (2003) 0.78
Defining a clinically significant adverse impact of diagnosing Barrett's esophagus. J Clin Gastroenterol (2006) 0.78
Esophageal varices on computed tomography and subsequent variceal hemorrhage. Abdom Imaging (2014) 0.77
Diversity of endoscopy center operations and practice variation across California's safety-net hospital system: a statewide survey. BMC Res Notes (2013) 0.77
Gastric cancer in asian american populations: a neglected health disparity. Asian Pac J Cancer Prev (2014) 0.76
Proton pump inhibitors and hip fracture: cause for alarm? Gastroenterology (2007) 0.75
Patients prefer conventional to virtual colonoscopy. Gastroenterology (2007) 0.75
Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening? Gastroenterology (2007) 0.75
Inoperable pancreatic cancer patients who have prolonged survival exhibit an increased risk of cholangitis. JOP (2011) 0.75
Is 325 mg of prevention worth a pound of cure? Gastroenterology (2012) 0.75
Dysphagia drives doctors to diagnose a disease: pitfalls in interpreting observational studies. Gastrointest Endosc (2005) 0.75
Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinoma. Am J Gastroenterol (2009) 0.75
Development of a Practical Model for Targeting Patient Decision Support Interventions to Promote Colorectal Cancer Screening in Vulnerable Populations. J Health Care Poor Underserved (2016) 0.75
The development of clinical guidelines by the American Gastroenterological Association. Gastroenterology (2009) 0.75
Evidence based medicine (EBM) in practice: applying results of cost-effectiveness analyses. Am J Gastroenterol (2006) 0.75
Fear of loss, not promise of gain, drives practice patterns in Barrett's esophagus. Gastroenterology (2008) 0.75
The AGA institute process for developing clinical practice guidelines part one: grading the evidence. Clin Gastroenterol Hepatol (2013) 0.75
A cost-identification analysis of screening and surveillance of hepatitis C infection in a prospective cohort of dialysis patients. Dig Dis Sci (2007) 0.75
Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test. Indian J Gastroenterol (2011) 0.75
How to recognize a good guideline. Gastroenterology (2013) 0.75